Pan-Cancer Early Detection: Hype or Hope?

被引：23
|
作者：
Srivastava, Sudhir [1 ]
Hanash, Sam [2 ]
机构：
[1] NCI, Canc Biomarkers Res Grp, Div Canc Prevent, NIH, Bethesda, MD 20892 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, McCombs Inst Canc Early Detect & Treatment, Houston, TX 77030 USA
来源：
CANCER CELL | 2020年 / 38卷 / 01期
关键词：
D O I：
10.1016/j.ccell.2020.05.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Universal cancer screening based on circulating DNA, proteins, metabolites, or other combinations has the potential to revolutionize early cancer detection, especially for cancers with no available screening modalities. Two recent publications in Science and Annals of Oncology highlight the potential benefits and limitations of single-test, multiple cancer screens.
引用
收藏
页码：23 / 24
页数：2
相关论文
共 50 条
  • [1] The promise of liquid biopsy in the early detection of cancer: Hope or hype?
    Srivastava, Sudhir
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 16 - 17
  • [2] The pan-cancer noninvasive screening and early detection by epigenetic techniques
    Yang, Yong
    Qin, Yang
    Zeng, Zhen
    Lu, Yinying
    Gong, Yuan
    Li, Yuemin
    Song, Lele
    [J]. EPIGENOMICS, 2021, 13 (09) : 649 - 652
  • [3] Trastuzumab for early breast cancer: Hope or hype?
    Smith, Ian E.
    [J]. BREAST CARE, 2006, 1 (02) : 66 - 67
  • [4] PAN-CANCER EARLY DETECTION TESTS: CONSIDERING POTENTIAL BENEFITS AND HARMS
    Jiao, B.
    Gulati, R.
    Etzioni, R.
    [J]. VALUE IN HEALTH, 2021, 24 : S51 - S52
  • [5] SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection
    Kolekar, Pandurang
    Balagopal, Vidya
    Dong, Li
    Liu, Yanling
    Foy, Scott
    Tran, Quang
    Mulder, Heather
    Huskey, Anna L. W.
    Plyler, Emily
    Liang, Zhikai
    Ma, Jingqun
    Nakitandwe, Joy
    Gu, Jiali
    Namwanje, Maria
    Maciaszek, Jamie
    Payne-Turner, Debbie
    Mallampati, Saradhi
    Wang, Lu
    Easton, John
    Klco, Jeffery M.
    Ma, Xiaotu
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (18) : 4100 - 4114
  • [6] Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?
    Duffy, Michael J.
    Crown, John
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (04) : 241 - 253
  • [7] Metformin: Hype or Hope for Cancer
    Nar, Asli
    [J]. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2017, 27 (04): : 258 - 266
  • [8] Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies
    Constantin, Nicolas
    Sina, Abu Ali Ibn
    Korbie, Darren
    Trau, Matt
    [J]. EPIGENOMES, 2022, 6 (01)
  • [9] Hope and hype for cancer drugs
    不详
    [J]. NATURE MEDICINE, 2004, 10 (01) : 8 - 8
  • [10] A pan-cancer atlas
    Nawy, Tal
    [J]. NATURE METHODS, 2018, 15 (06) : 407 - 407
12345